{"id":"https://openalex.org/W38540792","doi":null,"title":"Tolerability and Pharmacokinetics of Ingenol Mebutate 0.05% Gel Applied to Treatment Areas up to 100cm(2) on the Forearm(s) of Patients with Actinic Keratosis.","display_name":"Tolerability and Pharmacokinetics of Ingenol Mebutate 0.05% Gel Applied to Treatment Areas up to 100cm(2) on the Forearm(s) of Patients with Actinic Keratosis.","publication_year":2014,"publication_date":"2014-12-01","ids":{"openalex":"https://openalex.org/W38540792","mag":"38540792","pmid":"https://pubmed.ncbi.nlm.nih.gov/25584134","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4285446"},"language":"en","primary_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4285446","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4285446","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Aesthet Dermatol","raw_type":"Text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4285446","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042746925","display_name":"Lawrence L. Anderson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lawrence Anderson","raw_affiliation_strings":["Dermatology Associates of Tyler, Texas;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Associates of Tyler, Texas;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109224242","display_name":"Michael Jarratt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210129766","display_name":"DermResearch (United States)","ror":"https://ror.org/03np5z244","country_code":"US","type":"company","lineage":["https://openalex.org/I4210129766"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Jarratt","raw_affiliation_strings":["DermResearch Inc., Austin, Texas;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DermResearch Inc., Austin, Texas;","institution_ids":["https://openalex.org/I4210129766"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109988495","display_name":"George J Schmieder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130535","display_name":"Park Avenue Dermatology","ror":"https://ror.org/03gyv3q15","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210130535"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George Schmieder","raw_affiliation_strings":["Park Avenue Dermatology, Orange Park, Florida;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Park Avenue Dermatology, Orange Park, Florida;","institution_ids":["https://openalex.org/I4210130535"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051075012","display_name":"Stephen P. Shumack","orcid":"https://orcid.org/0000-0002-9121-7795","observed_orcids":["https://orcid.org/0000-0002-9121-7795"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Stephen Shumack","raw_affiliation_strings":["University of Sydney, Sydney, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Sydney, Sydney, Australia;","institution_ids":["https://openalex.org/I129604602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020812145","display_name":"Janelle Katsamas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2197358","display_name":"Leo Pharma (Australia)","ror":"https://ror.org/00vvs5b96","country_code":"AU","type":"company","lineage":["https://openalex.org/I2197358","https://openalex.org/I4210124980","https://openalex.org/I4210165112"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Janelle Katsamas","raw_affiliation_strings":["LEO Pharma Pty Ltd, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LEO Pharma Pty Ltd, Brisbane, Australia","institution_ids":["https://openalex.org/I2197358"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074733519","display_name":"Peter Welburn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2197358","display_name":"Leo Pharma (Australia)","ror":"https://ror.org/00vvs5b96","country_code":"AU","type":"company","lineage":["https://openalex.org/I2197358","https://openalex.org/I4210124980","https://openalex.org/I4210165112"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Peter Welburn","raw_affiliation_strings":["LEO Pharma Pty Ltd, Brisbane, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LEO Pharma Pty Ltd, Brisbane, Australia","institution_ids":["https://openalex.org/I2197358"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.1245,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.90525669,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"7","issue":"12","first_page":"19","last_page":"29"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11013","display_name":"Skin Protection and Aging","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ingenol-mebutate","display_name":"ingenol mebutate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/actinic-keratosis","display_name":"actinic keratosis","score":0.9869999885559082},{"id":"https://openalex.org/keywords/topical-gel","display_name":"topical gel","score":0.8519999980926514},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7699999809265137},{"id":"https://openalex.org/keywords/systemic-absorption","display_name":"systemic absorption","score":0.9240000247955322},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.718999981880188},{"id":"https://openalex.org/keywords/local-skin-reactions","display_name":"local skin reactions","score":0.6830000281333923},{"id":"https://openalex.org/keywords/primary-metabolites","display_name":"primary metabolites","score":0.7369999885559082}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9598413705825806},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8992279767990112},{"id":"https://openalex.org/C2777873816","wikidata":"https://www.wikidata.org/wiki/Q422225","display_name":"Actinic keratosis","level":3,"score":0.8017268180847168},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7408878803253174},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5514784455299377},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4457281529903412},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4454379081726074},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3274588882923126},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29388338327407837},{"id":"https://openalex.org/C3019992690","wikidata":"https://www.wikidata.org/wiki/Q92767510","display_name":"Basal cell","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"pmh:oai:pubmedcentral.nih.gov:4285446","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4285446","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Aesthet Dermatol","raw_type":"Text"},{"id":"pmid:25584134","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25584134","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical and aesthetic dermatology","raw_type":"Journal Article"},{"id":"mag:38540792","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25584134","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:4285446","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4285446","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Aesthet Dermatol","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W52072899","https://openalex.org/W1516412056","https://openalex.org/W1636503868","https://openalex.org/W1967228882","https://openalex.org/W1979971106","https://openalex.org/W1983139512","https://openalex.org/W1993827451","https://openalex.org/W1996274389","https://openalex.org/W1998023572","https://openalex.org/W2025044015","https://openalex.org/W2029583816","https://openalex.org/W2033489456","https://openalex.org/W2036548669","https://openalex.org/W2053558823","https://openalex.org/W2072284949","https://openalex.org/W2074259943","https://openalex.org/W2105697859","https://openalex.org/W2111417971","https://openalex.org/W2120639911","https://openalex.org/W2124427511","https://openalex.org/W2126008497","https://openalex.org/W2132174517","https://openalex.org/W2133518948","https://openalex.org/W2140683149","https://openalex.org/W2402365618","https://openalex.org/W2497721881","https://openalex.org/W4291944135","https://openalex.org/W6979014210"],"related_works":["https://openalex.org/W2614428904","https://openalex.org/W4252285216","https://openalex.org/W1962646960","https://openalex.org/W2778357270","https://openalex.org/W2887708856","https://openalex.org/W2485109283","https://openalex.org/W2965288399","https://openalex.org/W4250523908","https://openalex.org/W4244846753","https://openalex.org/W2964946855"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"determine":[2],"safety,":[3],"tolerability,":[4],"and":[5,49,79,107,122,133,138,156,171,236],"systemic":[6,206,243],"absorption":[7,244],"of":[8,27,180,195,249],"ingenol":[9,136,209],"mebutate":[10,137,210,217],"0.05%":[11,218],"gel":[12,219],"applied":[13,226],"for":[14,101,123,135],"two":[15],"consecutive":[16],"days":[17],"to":[18,22,95,125,208,227,231,247],"treatment":[19,185,228],"areas":[20,229,248],"up":[21,124,230],"100cm(2)":[23,184,232],"on":[24,130,149],"the":[25,72,89,114,162,178,181,192],"forearm(s)":[26],"patients":[28,66,81,93],"with":[29,233],"actinic":[30],"keratosis.":[31],"DESIGN":[32],"AND":[33],"SETTING:":[34],"Two":[35],"studies":[36],"are":[37],"reported:":[38],"a":[39,50,188,221],"Phase":[40,51,61,73,90,163],"1,":[41],"multicenter,":[42],"open-label,":[43],"dose-area":[44,97],"escalation":[45],"cohort":[46],"study":[47,56,63,75],"(http://www.clinicaltrials.gov/ct2/show/NCT00659893)":[48],"2,":[52,132,151],"double-blind,":[53],"vehicle-controlled":[54],"pharmacokinetic":[55,115],"(http://clinical":[57],"trials.gov/ct2/show/NCT00852137).":[58],"PARTICIPANTS:":[59],"The":[60,183],"1":[62,91,164],"included":[64,76],"male":[65,78],"(n=65),":[67],"mean":[68,83,196],"age":[69,84],"68.1":[70],"years;":[71],"2":[74],"both":[77,143],"female":[80],"(n=16),":[82],"63.3":[85],"years.":[86],"MEASUREMENTS:":[87],"In":[88,113,142,161],"study,":[92,116,165],"assigned":[94],"escalating":[96],"cohorts":[98],"were":[99,119,147,169],"evaluated":[100],"local":[102,198,237],"skin":[103,199,238],"responses,":[104],"adverse":[105,167,174],"events,":[106],"any":[108],"other":[109],"relevant":[110],"safety":[111,145,223],"data.":[112],"blood":[117],"samples":[118],"collected":[120],"pre-dose":[121],"24":[126],"hours":[127],"after":[128],"administration":[129],"Day":[131],"analyzed":[134],"its":[139,212],"primary":[140,213],"metabolites.":[141,214],"studies,":[144],"assessments":[146],"performed":[148],"Days":[150],"3,":[152],"8,":[153],"15,":[154],"29,":[155],"57":[157],"(study":[158],"end).":[159],"RESULTS:":[160],"most":[166],"events":[168,175],"mild,":[170],"all":[172],"treatment-related":[173],"resolved":[176],"before":[177],"end":[179],"study.":[182],"area":[186],"showed":[187],"small":[189],"increase":[190],"in":[191],"overall":[193],"intensity":[194],"composite":[197],"response":[200],"scores.":[201],"There":[202,240],"was":[203],"no":[204,242],"quantifiable":[205],"exposure":[207],"or":[211],"CONCLUSION:":[215],"Ingenol":[216],"has":[220],"good":[222],"profile":[224],"when":[225],"acceptable":[234],"tolerability":[235],"responses.":[239],"is":[241],"following":[245],"application":[246],"100cm(2).":[250]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2016-06-24T00:00:00"}